Advanced Cell Technology gets 2 patents related to retinal cells

09/15/2010 | Mass High Tech (Boston)

Advanced Cell Technology has received a patent to use retinal pigment epithelial cells derived from human embryonic stem cells in the treatment of retinal degeneration. The company also received another patent that allows it to produce RPE cells for use in transplantation. The patents will enable the company to test its cell treatment for Stargardt's disease.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX